Menu ×

HEALTHCARE & PHARMACEUTICAL

In Vitro Diagnostics (IVD) Market Segmentation By Product Type (Instruments, Reagents & Software & Services); By Technique (Hematology, Molecular Diagnostics, POC Testing, Histochemistry, Immunochemistry, Self-Blood Glucose Testing & Others); By Application (Diabetes, Infectious Diseases, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, Infectious Disease, Gastrointestinal Diseases); By Usability; By End User – Global Demand Analysis & Opportunity Outlook 2027

  • Text Size:

Introduction to In Vitro Diagnostics

In-Vitro diagnostics are medical tests that are performed on samples such as tissue or blood which have been taken from the human body. Its major purpose is to detect several diseases which can be further used to effectively monitor the overall health of the person to prevent and treat diseases. Technically, these tests are executed in an artificial environment and are an important segment in the worldwide healthcare industry, extensively used in the field of precision medicine.

IVD products includes reagents, instruments or any kind of systems which are specifically used for the diagnosis of a disease. The tests are typically conducted in hospital-based laboratories or stand-alone laboratories. Technologies which are incorporated in it includes microarray techniques, sequencing technology, mass spectrometry, polymerase chain reaction etc.

Market Size and Forecast

The market is observing vibrant growth on account of increasing geriatric population and enhancement in the incidence of infectious and chronic diseases. Growing investment in the healthcare sector by various government and private organizations along with rising demand for POC (Point of Care) devices is expected to drive the market over the forecast period. Further, increasing awareness regarding automated devices coupled with growing trend of personalized medicine are expected to accelerate the growth of the market. Additionally, the rise in the number of private and public diagnostic centers is also expected to increment the growth of the market over the forecast period i.e. 2019-2027.

The global in -vitro diagnostic market is anticipated to record a CAGR of 4.85% over the forecast period. The market is segmented by product type into instruments, reagents and software & services, out of which, the instrument segment is anticipated to capture the highest market share during the forecast period owing to growing rate of advancements in these tests. The market is further segmented by application into diabetes, infectious diseases, oncology, cardiology, nephrology, autoimmune diseases, drug testing, infectious disease, gastrointestinal diseases and others, out of which, the oncology segment is anticipated to grow significantly. Additionally, rising prevalence of cancer across the globe is supporting the growth of the market.CLICK TO DOWNLOAD FREE SAMPLE REPORT

In vitro diagnostics market Graph

Growth Drivers

Enhancing prevalence of chronic diseases

The prevalence of chronic disease is growing at an exponential pace which will specifically require various types of medical interventions. In-vitro diagnostics are widely used to detect several chronic and infectious diseases. According to the report of the World Health Organization (WHO), in the year 2001, chronic diseases added about 60% of 56.5 million reported deaths worldwide and about 46% of the global burden of disease. The proportion of burden of NCD’s is anticipated to rise to 57% by the year 2020. Half of the total deaths related to chronic diseases including diabetes and cardiovascular diseases are rising rapidly. This increase in the number of chronic diseases worldwide is anticipated to boost the growth of the market over the forecast period.

Increasing Cancer Patients

According to the World Health Organization, the global cancer burden has grown to 18.1 million new cases and the number of deaths on account of cancer is 9.6 million in 2018. There is a prevalence of various types of cancer including breast, bronchus, skin, lung, prostate and others which is further estimated o increase in upcoming years. This growth in the number of cancer cases around the various regions of the world is anticipated to boost the market growth over the forecast period.

Restraints

Stringent Government Regulations

Strict government regulations in various countries for the manufacturing of in-vitro diagnostic products coupled with inadequate reimbursement policies might hamper the growth of the market during the forecast period.

Market Segmentation

Our-in depth analysis of the global in-vitro diagnostics market includes the following segments:

By Product Type

  • Instruments
  • Reagents
  • Software & Services

By Technique

  • Hematology
  • Molecular Diagnostics
  • POC Testing
  • Histochemistry
  • Immunochemistry
  • Self-Blood Glucose Testing
  • Others

By Application

  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Infectious Disease
  • Gastrointestinal Diseases
  • Others

By Usability

  • Reusable IVD Devices
  • Disposable IVD Devices

By End User

  • Hospitals
  • Standalone Laboratory
  • Academic & Medical Institutions
  • Point of Care Testing
  • Others

By Region

On the basis of regional analysis, the global in-vitro diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America is anticipated to dominate market on account of increase in the geriatric population and effective reimbursement policies. Rising prevalence of chronic diseases coupled with increase in expenditure in the healthcare industry are some of the prime factors to support the market growth in this region.

Additionally, the Asia-Pacific region is expected have the fastest growing market on account of rise in the healthcare expenditure, increasing investment by the government and large patient pool. Moreover, the healthcare awareness across the region is estimated to augment the overall growth of the market of in-vitro diagnostics.

The global in-vitro diagnostics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Key Players

  • Bio-Rad Laboratories
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Abbott Laboratories
  • Johnson & Johnson
  • F. Hoffmann-La Roche Ltd.
  • Dickinson and Company
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers
  • Diasorin
  • Other Prominent Players
Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Related Reports


Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved

paypal visa americanexpress discover mastercard wire-transfer godaddy DMCA